{
  "docId": "019de073-ec7b-760b-b9a4-60ceb97e90d9",
  "docSlug": "fef1528177829f37cded553f72a56b72",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 44 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 44,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a '+' symbol to represent the acquisition/integration of LogicBio's platforms into Alexion's R&D pipeline.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ec7b-760b-b9a4-60ceb97e90d9/28",
  "deckHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9",
  "deckJsonHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9.json",
  "deckAnchorHref": "/decks/019de073-ec7b-760b-b9a4-60ceb97e90d9#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.63,
        "x": 0.345,
        "y": 0.725
      },
      "kind": "callout",
      "text": "Novel technology and manufacturing platforms have potential to accelerate Alexion programmes",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a240d180-525a-4985-8c0d-d516efa399c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.28,
        "x": 0.68,
        "y": 0.4
      },
      "kind": "image",
      "text": "GeneRide, sAAVy, mAAVRx icons",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "40a1a9c6-94ff-43f0-beaf-d8479499c8d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.265,
        "x": 0.351,
        "y": 0.39
      },
      "kind": "list",
      "text": "Gene therapy, Antisense oligonucleotides, CRISPR gene editing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0fc057be-1cfb-47c0-9e12-cac960aa6a4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.756,
        "y": 0.286
      },
      "kind": "paragraph",
      "text": "LogicBio novel technology platforms",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85419c44-de2e-4901-a5ac-f76f2a839d9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.265,
        "x": 0.351,
        "y": 0.286
      },
      "kind": "paragraph",
      "text": "Alexion genomic medicines leveraging existing AstraZeneca technologies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cbac228-56b7-4a39-a682-a1e99d067eca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.55,
        "x": 0.385,
        "y": 0.975
      },
      "kind": "source-note",
      "text": "CRISPR = clustered regularly interspaced short palindromic repeats; AAV = adeno-associated virus.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa708170-78f8-4dd7-9301-258c67b66ded",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.635,
        "x": 0.356,
        "y": 0.136
      },
      "kind": "title",
      "text": "Proposed LogicBio acquisition enhances genomic capabilities",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f99fe57-b9de-4614-bc17-9870c16966f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.335,
        "x": 0.356,
        "y": 0.068
      },
      "kind": "title",
      "text": "Rare Disease: R&D highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc6045db-2f97-4cc7-8f7d-669aac354269",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "41fd91cc-1d42-4a54-b76d-3f79819b7faf",
      "evidence": "The slide shows two distinct sets of capabilities being combined to create a new, enhanced state.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}